相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia
Marcela Braga Mansur et al.
BMC CANCER (2012)
T-cell acute lymphoblastic leukaemia: recent molecular biology findings
Monika D. Kraszewska et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Kinome-wide Selectivity Profiling of ATP-competitive Mammalian Target of Rapamycin (mTOR) Inhibitors and Characterization of Their Binding Kinetics
Qingsong Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Glycogen synthase kinase 3 beta positively regulates Notch signaling in vascular smooth muscle cells: role in cell proliferation and survival
Shaunta Guha et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
S. J. Shuttleworth et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase
Jung-Soon Mo et al.
JOURNAL OF CELL SCIENCE (2011)
Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL
Xiaoyu Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia
Alejandro Gutierrez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia
C. Evangelisti et al.
LEUKEMIA (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer
Markus K. Muellner et al.
NATURE CHEMICAL BIOLOGY (2011)
A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)
Konstantinos J. Mavrakis et al.
NATURE GENETICS (2011)
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms
Pixu Liu et al.
NATURE MEDICINE (2011)
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
Dan R. Robinson et al.
NATURE MEDICINE (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis
Nina Ilic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells
Hongfang Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Activity of the Novel Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 against T-Cell Acute Lymphoblastic Leukemia
Francesca Chiarini et al.
CANCER RESEARCH (2010)
c-Myc Regulates Transcriptional Pause Release
Peter B. Rahl et al.
CELL (2010)
PIKing the Right Patient
Alexa B. Turke et al.
CLINICAL CANCER RESEARCH (2010)
mTOR and cancer: many loops in one pathway
Alejo Efeyan et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
PI3K inhibitors for cancer treatment: where do we stand?
Sauveur-Michel Maira et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases
Ila Joshi et al.
BLOOD (2009)
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study
Vahid Asnafi et al.
BLOOD (2009)
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
Alejandro Gutierrez et al.
BLOOD (2009)
FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma
Myoung-Ja Park et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Dual Inhibition of Class IA Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin as a New Therapeutic Option for T-Cell Acute Lymphoblastic Leukemia
Francesca Chiarini et al.
CANCER RESEARCH (2009)
Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells
Sudhir S. Rao et al.
CANCER RESEARCH (2009)
Identification of novel Notch target genes in T cell leukaemia
Nicholas Chadwick et al.
MOLECULAR CANCER (2009)
Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy
Nathan T. Ihle et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group
A. Larson Gedman et al.
LEUKEMIA (2009)
Regulation of Notch1/NICD and Hes1 Expressions by GSK-3 alpha/beta
Yun Hye Jin et al.
MOLECULES AND CELLS (2009)
Direct inhibition of the NOTCH transcription factor complex
Raymond E. Moellering et al.
NATURE (2009)
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
Anthony C. Faber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Notch signaling in leukemia
Jon C. Aster et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Targeting phosphoinositide 3-kinase - Moving towards therapy
Romina Marone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
The role of the PTEN/AKT pathway in NOTCH1-induced leukemia
Teresa Palomero et al.
CELL CYCLE (2008)
Down-regulation of Notch-dependent transcription by Akt in vitro
Jieun Song et al.
FEBS LETTERS (2008)
In vitro validation of γ-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia
Kim De Keersmaecker et al.
HAEMATOLOGICA (2008)
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability
Ana Silva et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia
Federica Fala et al.
MOLECULAR PHARMACOLOGY (2008)
Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation
Wei Guo et al.
NATURE (2008)
Notch-1 mutations are secondary events in some patients with T-Cell acute lymphoblastic leukemia
Marc R. Mansour et al.
CLINICAL CANCER RESEARCH (2007)
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Teresa Palomero et al.
NATURE MEDICINE (2007)
Improved low molecular weight Myc-Max inhibitors
Huabo Wang et al.
MOLECULAR CANCER THERAPEUTICS (2007)
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
Jennifer O'Neil et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia
Steven M. Chan et al.
BLOOD (2007)
Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling
Huw D. Lewis et al.
CHEMISTRY & BIOLOGY (2007)
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth
Teresa Palomero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia
Stephen Breit et al.
BLOOD (2006)
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Andrew P. Weng et al.
GENES & DEVELOPMENT (2006)
A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling
Zachary A. Knight et al.
CELL (2006)
NOTCH1 mutations in T-cell acute lymphoblastic leukemia:: Prognostic significance and implication in multifactorial leukemogenesis
Yong-Mei Zhu et al.
CLINICAL CANCER RESEARCH (2006)
High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia
MR Mansour et al.
LEUKEMIA (2006)
A pharmacological map of the PI3-K family defines a role for p110 alpha in insulin signaling
Zachary A. Knight et al.
CELL (2006)
Inhibition of phosphatidylinositol 3′-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway
S Uddin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Phosphorylation by glycogen synthase kinase-3β down-regulates Notch activity, a link for Notch and Wnt pathways
L Espinosa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases
L Tatton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Requirement for cyclin D3 in lymphocyte development and T cell leukemias
E Sicinska et al.
CANCER CELL (2003)
Glycogen synthase kinase-3β modulates notch signaling and stability
DR Foltz et al.
CURRENT BIOLOGY (2002)
分享论文
